These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35988220)

  • 1. Plasma Neurofilament Light Chain and Clinical Diagnosis in Frontotemporal Dementia Syndromes.
    Ooi S; Patel SK; Eratne D; Kyndt C; Reidy N; Lewis C; Lee SCM; Darby D; Brodtmann A
    J Alzheimers Dis; 2022; 89(4):1221-1231. PubMed ID: 35988220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of neurofilament light chain in frontotemporal dementia: a meta-analysis.
    Karantali E; Kazis D; Chatzikonstantinou S; Petridis F; Mavroudis I
    Aging Clin Exp Res; 2021 Apr; 33(4):869-881. PubMed ID: 32306372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid neurofilament light chain differentiates behavioural variant frontotemporal dementia progressors from non-progressors.
    Eratne D; Keem M; Lewis C; Kang M; Walterfang M; Farrand S; Loi S; Kelso W; Cadwallader C; Berkovic SF; Li QX; Masters CL; Collins S; Santillo A; Velakoulis D;
    J Neurol Sci; 2022 Nov; 442():120439. PubMed ID: 36201960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia.
    Landqvist Waldö M; Frizell Santillo A; Passant U; Zetterberg H; Rosengren L; Nilsson C; Englund E
    BMC Neurol; 2013 May; 13():54. PubMed ID: 23718879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum.
    Meeter LHH; Vijverberg EG; Del Campo M; Rozemuller AJM; Donker Kaat L; de Jong FJ; van der Flier WM; Teunissen CE; van Swieten JC; Pijnenburg YAL
    Neurology; 2018 Apr; 90(14):e1231-e1239. PubMed ID: 29514947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia.
    Rohrer JD; Woollacott IO; Dick KM; Brotherhood E; Gordon E; Fellows A; Toombs J; Druyeh R; Cardoso MJ; Ourselin S; Nicholas JM; Norgren N; Mead S; Andreasson U; Blennow K; Schott JM; Fox NC; Warren JD; Zetterberg H
    Neurology; 2016 Sep; 87(13):1329-36. PubMed ID: 27581216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders.
    Gendron TF; Heckman MG; White LJ; Veire AM; Pedraza O; Burch AR; Bozoki AC; Dickerson BC; Domoto-Reilly K; Foroud T; Forsberg LK; Galasko DR; Ghoshal N; Graff-Radford NR; Grossman M; Heuer HW; Huey ED; Hsiung GR; Irwin DJ; Kaufer DI; Leger GC; Litvan I; Masdeu JC; Mendez MF; Onyike CU; Pascual B; Ritter A; Roberson ED; Rojas JC; Tartaglia MC; Wszolek ZK; Rosen H; Boeve BF; Boxer AL; ; Petrucelli L
    Cell Rep Med; 2022 Apr; 3(4):100607. PubMed ID: 35492244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
    Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
    J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia.
    Giuffrè GM; Quaranta D; Costantini EM; Citro S; Martellacci N; De Ninno G; Vita MG; Guglielmi V; Rossini PM; Calabresi P; Marra C
    Neurobiol Dis; 2023 Oct; 186():106267. PubMed ID: 37652185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration.
    Scherling CS; Hall T; Berisha F; Klepac K; Karydas A; Coppola G; Kramer JH; Rabinovici G; Ahlijanian M; Miller BL; Seeley W; Grinberg LT; Rosen H; Meredith J; Boxer AL
    Ann Neurol; 2014 Jan; 75(1):116-26. PubMed ID: 24242746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival.
    Skillbäck T; Mattsson N; Blennow K; Zetterberg H
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Aug; 18(5-6):397-403. PubMed ID: 28631955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
    Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K
    JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional brain abnormalities place phenocopy frontotemporal dementia (FTD) in the FTD spectrum.
    Steketee RME; Meijboom R; Bron EE; Osse RJ; de Koning I; Jiskoot LC; Klein S; de Jong FJ; van der Lugt A; van Swieten JC; Smits M
    Neuroimage Clin; 2016; 11():595-605. PubMed ID: 27222795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofilament Light Chain Levels in Frontotemporal Dementia and Progressive Supranuclear Palsy: A Systematic Review.
    Bendstrup N; Hejl AM; Salvesen L
    J Alzheimers Dis; 2022; 87(1):131-140. PubMed ID: 35275542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia.
    Al Shweiki MR; Steinacker P; Oeckl P; Hengerer B; Danek A; Fassbender K; Diehl-Schmid J; Jahn H; Anderl-Straub S; Ludolph AC; Schönfeldt-Lecuona C; Otto M
    J Psychiatr Res; 2019 Jun; 113():137-140. PubMed ID: 30953863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma neurofilament light in behavioural variant frontotemporal dementia compared to mood and psychotic disorders.
    Eratne D; Kang M; Malpas C; Simpson-Yap S; Lewis C; Dang C; Grewal J; Coe A; Dobson H; Keem M; Chiu WH; Kalincik T; Ooi S; Darby D; Brodtmann A; Hansson O; Janelidze S; Blennow K; Zetterberg H; Walker A; Dean O; Berk M; Wannan C; Pantelis C; Loi SM; Walterfang M; Berkovic SF; Santillo AF; Velakoulis D
    Aust N Z J Psychiatry; 2024 Jan; 58(1):70-81. PubMed ID: 37477141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF Biomarkers of Neurodegeneration in Progressive Non-fluent Aphasia and Other Forms of Frontotemporal Dementia: Clues for Pathomechanisms?
    Körtvelyessy P; Heinze HJ; Prudlo J; Bittner D
    Front Neurol; 2018; 9():504. PubMed ID: 30013506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid and blood neurofilament light chain levels in amyotrophic lateral sclerosis and frontotemporal degeneration: A meta-analysis.
    Verde F; Licaj S; Soranna D; Ticozzi N; Silani V; Zambon A
    Eur J Neurol; 2024 Sep; 31(9):e16371. PubMed ID: 38937912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood Neurofilament Light Chain in Different Types of Dementia.
    Gu L; Shu H; Wang Y; Wang P
    Curr Alzheimer Res; 2023; 20(3):149-160. PubMed ID: 37264656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma neurofilament light protein correlates with diffusion tensor imaging metrics in frontotemporal dementia.
    Spotorno N; Lindberg O; Nilsson C; Landqvist Waldö M; van Westen D; Nilsson K; Vestberg S; Englund E; Zetterberg H; Blennow K; Lätt J; Markus N; Lars-Olof W; Alexander S
    PLoS One; 2020; 15(10):e0236384. PubMed ID: 33108404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.